Skip to content
PICO Portalanswers from OpenAlex

Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries

PaperCitations, authors & open-access status

Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries is a paper indexed in PICO Portal from OpenAlex.

How many citations does Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries have?

PICO Portalcitation count

Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries has 6 citations in the OpenAlex counts PICO Portal stores.

When was Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries published?

PICO Portalyear

Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries has 2009 year in the PICO Portal index.

What is the open-access status of Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries?

PICO Portaloa status

Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries has closed oa status in the PICO Portal index.

What is the OpenAlex record for Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries?

PICO Portalopenalex

The OpenAlex for Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial